Quick Answer
MEDICINOVA INC reported Operating Income Loss of -$13.28 million for the year ending 2025.
- MEDICINOVA INC showed a decrease of -4.8% in Operating Income Loss from 2024 to 2025.
- This data is from MEDICINOVA INC's annual report (Form 10-K), filed with the SEC on March 10, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), MEDICINOVA INC's Operating Income Loss has grown by 37.5%.
- Historical annual values: Fiscal year 2025: -$13.28 million | Fiscal year 2024: -$12.68 million | Fiscal year 2023: -$9.90 million | Fiscal year 2022: -$14.63 million | Fiscal year 2021: -$10.22 million | Fiscal year 2020: -$14.18 million | Fiscal year 2019: -$14.03 million | Fiscal year 2018: -$15.59 million | Fiscal year 2017: -$13.03 million | Fiscal year 2016: -$10.88 million | Fiscal year 2015: -$8.82 million | Fiscal year 2014: -$9.22 million | Fiscal year 2013: -$4.02 million | Fiscal year 2012: -$10.95 million | Fiscal year 2011: -$16.11 million | Fiscal year 2010: -$17.88 million | Fiscal year 2009: -$21.24 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: